Digital CMC Deployment: Real-World Use Cases | Digital CMC Summit | Presentations & Panel Discussion

Discover how industry leaders are implementing digital CMC

In this series of expert presentations, transformation veterans from across the industry share their real-world experience with implementing, managing, and sustaining digital transformation in the CMC process.

As each of these six specialists explains, digitizing CMC operations is key to unlocking greater efficiency and productivity – both for established organizations and up-and-coming innovators. Each presenter offers a unique view of how digital CMC principles are already helping their team and organization achieve a new level of scientific and operational performance.

In this presentation series from the 2022 Digital CMC Summit:

• Gloria Gadea-Lopez explains why implementing digital CMC solutions is a critical first step in helping her customers prepare for a successful transition to Manufacturing 4.0. She explains how the right digital CMC platform can help drug developers lay a foundation of trackable, reusable, collaboration-friendly infrastructure for their product programs.
• Dr. Joschka Buyel offers an in-depth look at how his Bayer team manages the deployment of new digital CMC solutions, creates data taxonomies to maximize the value of those technologies, and leverages them to accelerate development of key assets like process descriptions.
• John Maguire shares how digital CMC principles have helped the Sanofi mRNA Center of Excellence shift from a legacy project-focused approach to a strategic platform approach – one that is already enabling them to significantly increase their throughput of valuable mRNA products.
• Steve Keizer delves into how his team at the Artisan Bio “Cell Foundry” discovered that a digital CMC platform can be the perfect development bridge between early-stage R&D workflows and commercial-scale GMP activities.
• Dr. Amol Thote and Justin Grahek share how Bayer Pharmaceutical uses a digital CMC platform to both streamline development of well-established substance classes and create scalable development platforms for cutting-edge cell and gene therapies.

Don’t miss the group discussion at the end, where these six experts field some insightful questions about how they’re managing the interdisciplinary collaboration at the heart of any digital transformation process.